In this study, we found that GNA13 was markedly overexpressed in GC tissues and closely associated with aggressive GC progression and poor survival outcome and that silencing GNA13 expression dramatically suppressed the proliferation and tumorigenicity of GC cells both in vitro and in vivo, whereas overexpressing GNA13 had the opposite effect. The gene discussed is GNA13; the disease is gastric cancer.